🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this retrospective observational cohort study is to assess p...
Status
Active Not Recruiting
Location
OptumInsight Life Sciences Inc
Start Date
2024-08-26
Trial ID
NCT06126835
Treatments Being Tested
The primary endpoint of this study is to evaluate the prevalence of anxiety...
Status
Completed
Location
IRCCS policlinico San Matteo - Reparto di Reumatologia
Start Date
2014-01
Trial ID
NCT02122406
Treatments Being Tested
The primary objective is to assess if discontinuation of anti- tumor necros...
Status
Completed
Location
Helse Møre og Romsdal, Ålesund Sjukehus
Start Date
2017-06-09
Trial ID
NCT03011268
Treatments Being Tested
RABIOPRED is an in vitro non-invasive blood test, which aims to identify pa...
Status
Terminated
Location
Institute of Rheumatology
Start Date
2016-12
Trial ID
NCT03016260
The purpose of this study is to evaluate the safety and efficacy of golimum...
Status
Completed
Location
Multiple Locations
Start Date
2010-09
Trial ID
NCT01248780
Treatments Being Tested
This is a Single Patient Investigational New Drug (IND) to golimumab subcut...
Status
No Longer Available
Location
Rady Children's Hospital
Start Date
TBD
Trial ID
NCT03945903
Treatments Being Tested
The purpose of this study is to evaluate the pharmacokinetics (the study of...
Status
Completed
Location
Multiple Locations
Start Date
2014-12-22
Trial ID
NCT02277444
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of golimum...
Status
Completed
Location
Multiple Locations
Start Date
2010-10
Trial ID
NCT01248793
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of guselkumab plus go...
Status
Completed
Location
Arizona Arthritis and Rheumatology Research PLLC
Start Date
2021-10-25
Trial ID
NCT05071664
Treatments Being Tested
Comparing the structural effects of TNFi and tocilizumab on the periarticul...
Status
Completed
Location
University Erlangen-Nuremberg, Medical Department 3, Rheumatology & Immunology
Start Date
2015-10
Trial ID
NCT02778789
Treatments Being Tested